Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

Todd Neale

November 03, 2025

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

Presentation TCT 2012

In-Hospital Experience of 'Real World' Patients Enrolled in the TAXUS Liberte Post-Approval Study: The TAXUS Liberte Stent with Concomitant Prasugrel Therapy

Presenter: David P. Lee, Kirk N. Garratt, Richard Paulus, Jeffrey Carr, Kartik Giri, Ameer Kabour, Kenneth J. Winters, Thomas S. Bowman, Keith D. Dawkins

January 03, 2012

Advertisement

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

In-Hospital Experience of 'Real World' Patients Enrolled in the TAXUS Liberte Post-Approval Study: The TAXUS Liberte Stent with Concomitant Prasugrel Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content